Understanding the ISBT 128 Chain of Identity (CoI) Identifier and Its Impact
In the evolving world of patient-specific therapies, the ISBT 128 Chain of Identity (CoI) Identifier stands as a crucial tool for safeguarding the journey of human-derived biological material, from donation through to administration. Unlike other identifiers, the ISBT 128 CoI Identifier provides a globally unique and structured system that ensures traceability and security throughout the entire lifecycle of these materials. By maintaining an unbroken chain of custody, this identifier enhances patient safety, helping to mitigate risks and ensure accurate treatment. With ICCBBA at the forefront of this initiative, discover how the ISBT 128 CoI Identifier is making a difference in the field.
What is the ISBT 128 Chain of Identity (CoI) Identifier?
The ISBT 128 Chain of Identity Identifier can connect multiple collections from donation through manufacturing to administration for patient-specific therapy.
How is the ISBT 128 CoI Identifier different from other CoI identifiers?
The ISBT 128 CoI Identifier varies from other CoI identifiers because it is a globally unique identifier. The ISBT 128 CoI Identifier follows a structured sequence of alphanumeric characters including a Facility Identification Number (FIN) assigned by ICCBBA to ensure global uniqueness.
How does the ISBT 128 CoI Identifier help improve patient safety?
The ISBT 128 CoI Identifier is used to secure the chain of custody throughout the lifecycle of human-derived biological material intended for patient-specific therapy.
Where can I find more information on the ISBT 128 Chain of Identity Identifier?
ICCBBA is hosting a webinar on September 24, 2024, focused on the ISBT 128 Chain of Identity Identifier featuring first-hand experience from users who have implemented the ISBT 128 CoI Identifier.
Learn more about how the ISBT 128 Chain of Identity Identifier can improve patient safety and make sure you register for our upcoming webinar.
Webinar Details:
Title: Forging Strong Links for Patient Safety: The Power of Implementing the ISBT 128 CoI Identifier
Webinar Date: September 24, 2024
Webinar Time:
PDT: Pacific Daylight Time 7:00 AM to 8:00 AM
UTC: Coordinated Universal Time 2:00 PM to 3:00 PM
Duration: 60 minutes.
Speakers:
Karen Moniz, Technical Director - ICCBBA
Robin Wilkinson, Deputy Technical Director - ICCBBA
Beth Gardner, Senior Director - Beam Therapeutics
Catherine McIntyre, Operations and Scientific Director, Blood and Marrow Transplant - Cellular Therapy Facility - Stanford Health Care
Nery Diaz, Assistant Manager Technical Operations CTF, Blood and Marrow Transplant - Cellular Therapy Facility - Stanford Health Care
Moderator: Alex Garlets, Information Standards Specialist - ICCBBA
Don't miss this opportunity to enhance your understanding and take the next step toward ensuring patient safety through the effective implementation of the ISBT 128 CoI Identifier.
Visit our webinar homepage to register: COI Identifier Webinar
If you have any questions or require further information, please do not hesitate to contact us at webinarsupport@isbt128.org.
ICCBBA Publications:
Stay connected, stay informed, and stay inspired with ICCBBA.
Subscribe to our newsletter at: https://www.isbt128.org/newsletter
About ICCBBA:
ICCBBA is the international standards organization responsible for the management and development of the ISBT 128 Standard.
The acronym ISBT was originally derived from the important role played by the International Society of Blood Transfusion in the development of the Standard. Today it expands as Information Standard for Blood and Transplantation. The number 128 reflects the 128 characters of the ISO/IEC 646 7-bit character set.
The acronym ICCBBA is derived from the International Council for Commonality in Blood Banking Automation.
For More Information About ICCBBA:
Media Contact: Christina Salinas
Email: support@isbt128.org
Author
Executive Assistant, ICCBBA
Comments